http://www.gstock.com/quote/rigl.html GStock alerts for Rigel Pharmaceuti (RIGL) en-us Tue, 02 Dec 2008 21:00:00 -0500 Tue, 02 Dec 2008 21:00:00 -0500 GStock RSS Feed http://www.gstock.com/quote/rigl.html GStock.com Supercomputer announced on Tuesday 2nd of December 2008 that a SELL alert has been issued to Rigel Pharmaceuti (RIGL). Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Our goal is to move one new product candidate for a significant indication into the clinic each year. We have achieved this goal since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, asthma and allergy, as well as in cancer Tue, 02 Dec 2008 21:00:00 -0500 http://www.gstock.com/quote/rigl.html